In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J’s IVD unit on the block – are GE and Danaher potential bidders?

This article was originally published in Clinica

Executive Summary

Rumors of Johnson & Johnson’s intention to cast off its Ortho Clinical Diagnostics unit picked up momentum following unconfirmed media reports that the healthcare giant has launched the sale process. Citing unnamed sources close to the matter, Reuters reported that J&J had hired JPMorgan Chase as bookkeepers for the deal, and that OCD – which has annual sales of $2bn – could fetch a hefty price tag of $5bn.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts